Proton-driven transformable nanovaccine for cancer immunotherapy.
Gong N, Zhang Y, Teng X, Wang Y, Huo S, Qing G, Ni Q, Li X, Wang J, Ye X, Zhang T, Chen S, Wang Y, Yu J, Wang PC, Gan Y, Zhang J, Mitchell MJ, Li J, Liang XJ.
Gong N, et al. Among authors: mitchell mj.
Nat Nanotechnol. 2020 Dec;15(12):1053-1064. doi: 10.1038/s41565-020-00782-3. Epub 2020 Oct 26.
Nat Nanotechnol. 2020.
PMID: 33106640
Free PMC article.